A. Hwang

A. Hwang

Former Chief Commercial Officer and President, Global Biopharmaceuticals BusinessatPfizer· In proxies 2021–2023

Pay in FY2022+8% from the year before

A. Hwang was paid $9.7M in FY2022 (Dec), up 8%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Pfizer proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PfizerPublic company · 5 yr
    • Former Chief Commercial Officer and President, Global Biopharmaceuticals Business2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?